The European Commission has approved SIFI's Akantior as the first therapy anywhere in the world for acanthamoeba keratitis (AK), an ultra-rare parasitic infection that can lead to blindness.

Corneal neurotization using STN/GAN grafts can improve corneal sensation and nerve density in neurotrophic keratopathy.